Why missing critical data slows oncology decision-making
For many clinical teams, the bottleneck is not data access itself but reaching the right data in the right sequence.
Missing stage details, unclear biomarker lines, or fragmented treatment history weaken trial screening, board prep, and report communication at once.
That is why a preparation layer must do more than collect records; it should expose missing critical fields explicitly.
Structured summaries do not replace clinical judgment; they reduce pre-decision ambiguity.